Acessa Health→Hologic
Acquisition · Cash · HOLX · announced Aug 25, 2020
Announced
Aug 25, 2020
Closed
Aug 25, 2020
Economics
Cash()
Pre-deal · pre-deal mark: 2020, year precision · Hologic press release — Acessa Health acquisition, 2020
~$80M cash + contingent revenue milestone payments
Target
Acessa Health
Gynecological Surgery · Clinical / therapeutic
HQ Redwood City, CA · Founded 2005
Minimally invasive radiofrequency ablation system (Acessa ProVu) for treatment of symptomatic uterine fibroids — alternative to hysterectomy
- Business Wire — Hologic press release (Aug 25, 2020)
- Hologic investor relations
Acquirer
Hologic (HOLX)
Breast Health
HQ Marlborough, MA
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Acessa ProVu radiofrequency ablation system broadens fibroid treatment portfolio — minimally invasive alternative to hysterectomy with less blood loss and faster recovery
Evidence ladder
Secondary (press / IR)
Business Wire — Hologic press release (Aug 25, 2020)
Limitations
- Single-source or weak corroboration — treat valuation and timing as directional.
- ~$80M cash + contingent revenue milestone payments
- Pre-deal valuation sourced from: Hologic press release — Acessa Health acquisition, 2020. Pre-deal market-cap and funding citations do not corroborate the acquisition.
Valuation peers · Gynecological Surgery
Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer.
| Target | Acquirer | Announced | Value | Why included |
|---|---|---|---|---|
| Bolder Surgical | Hologic | Oct 14, 2021 | same evidence class · same acquirer |
Other verified deals by Hologic
Acquirer program history not already listed as a valuation peer or adjacency row.
| Target | Acquirer | Announced | Value | Sector |
|---|---|---|---|---|
| Gynesonics | Hologic | Sep 15, 2024 | Gynecological Surgery | |
| Endomagnetics | Hologic | May 20, 2024 | Breast Health | |
| Biotheranostics | Hologic | Jan 5, 2021 | Breast Health | |
| SuperSonic Imagine | Hologic | Jun 21, 2019 | Breast Health | |
| Focal Therapeutics | Hologic | Sep 26, 2018 | Breast Health |
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — Acessa Health (Gynecological Surgery). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v9 · updated 2026-09-20 · 1 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.